Are you Dr. Weiner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3577 W 13 Mile Rd
Suite 204
Royal Oak, MI 48073Phone+1 248-551-2441Fax+1 248-551-1094
Summary
- Dr. Sheldon Weiner, MD is an obstetrician/gynecologist in Royal Oak, Michigan. He is currently licensed to practice medicine in Michigan and Arizona. He is affiliated with Corewell Health Farmington Hills Hospital and Corewell Health Grosse Pointe Hospital.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gynecologic Oncology, 1981 - 1983
- Corewell Health East Beaumont (Royal Oak)Residency, Obstetrics and Gynecology, 1978 - 1981
- Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1977 - 1978
- Wayne State University School of MedicineClass of 1977
Certifications & Licensure
- MI State Medical License 1978 - 2022
- AZ State Medical License 1983 - 2001
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 58 citationsPhase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical capGraham, E S Surwit, Sheldon A. Weiner, Frank L. Meyskens
The Western Journal of Medicine. 1986-08-01 - 55 citationsTamoxifen therapy in recurrent epithelial ovarian carcinoma.Sheldon A. Weiner, David S. Alberts, Earl A. Surwit, John R. Davis, David S. Grosso
Gynecologic Oncology. 1987-06-01 - 37 citationsA phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.Sheldon A. Weiner, Earl A. Surwit, Vivian Graham, Frank L. Meyskens
Investigational New Drugs. 1986-01-01